2138 주식 개요 투자 지주 회사인 EC 헬스케어는 홍콩, 마카오, 중화인민공화국에서 의료 및 헬스케어 서비스를 제공하는 기업입니다. 자세한 내용
생각, 링크 및 회사 내러티브를 캡처하세요.
가격 내역 및 성능
다음에 대한 주가 최고가, 최저가 및 변동 요약 EC Healthcare 과거 주가 현재 주가 HK$0.67 52주 최고치 HK$2.18 52주 최저치 HK$0.53 베타 1.39 1개월 변경 -5.63% 3개월 변경 사항 -17.28% 1년 변경 사항 -60.12% 3년 변화 -94.08% 5년 변화 -87.57% IPO 이후 변화 -77.52%
최근 뉴스 및 업데이트
Upcoming dividend of HK$0.01 per share Dec 23
EC Healthcare (HKG:2138) Shares Fly 29% But Investors Aren't Buying For Growth Dec 18
Dividend of HK$0.01 announced Nov 30
First half 2025 earnings released: EPS: HK$0.012 (vs HK$0.006 in 1H 2024) Nov 29
EC Healthcare Declares Ordinary Interim (Semi-Annual) Dividend for the Six Months Ended 30 September 2024, Payable on 24 January 2025 Nov 28
New minor risk - Market cap size Nov 13 더 많은 업데이트 보기
Upcoming dividend of HK$0.01 per share Dec 23
EC Healthcare (HKG:2138) Shares Fly 29% But Investors Aren't Buying For Growth Dec 18
Dividend of HK$0.01 announced Nov 30
First half 2025 earnings released: EPS: HK$0.012 (vs HK$0.006 in 1H 2024) Nov 29
EC Healthcare Declares Ordinary Interim (Semi-Annual) Dividend for the Six Months Ended 30 September 2024, Payable on 24 January 2025 Nov 28
New minor risk - Market cap size Nov 13
EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends Nov 13
EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024 Nov 09
Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024 Nov 08
Price target increased by 35% to HK$2.84 Oct 24
Less than half of directors are independent Oct 09
Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding Sep 05
EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024 Aug 16
Full year 2024 earnings: EPS and revenues miss analyst expectations Aug 04
EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively Jul 26
Full year 2024 earnings: EPS and revenues miss analyst expectations Jun 28
EC Healthcare, Annual General Meeting, Aug 23, 2024 Jun 28
EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024 Jun 15
An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million. Jun 14
EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement May 13
When Should You Buy EC Healthcare (HKG:2138)? Apr 26
Is EC Healthcare (HKG:2138) A Risky Investment? Feb 07
New minor risk - Share price stability Feb 02
EC Healthcare (SEHK:2138) entered into sale and purchase agreement to acquire 6.49% stake in Pangenia Inc from Sharp Point Consultant Limited for HKD 17.4 million. Jan 05
Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch Dec 24
EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005 Dec 08
EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023 Dec 08
Price target decreased by 15% to HK$5.22 Dec 05
First half 2024 earnings released: EPS: HK$0.006 (vs HK$0.068 in 1H 2023) Dec 02
Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital Dec 01
EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024 Nov 30
Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023 Nov 18
EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023 Nov 17 EC Healthcare Announces Executive Changes
At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely? Sep 15
Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023 Sep 02
Upcoming dividend of HK$0.042 per share at 2.6% yield Aug 25
EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042 Aug 24
Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023 Aug 24
Is EC Healthcare (HKG:2138) Using Too Much Debt? Aug 10
New minor risk - Earnings quality Jul 27
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Jul 27
EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042 Jul 14
Consensus EPS estimates fall by 31% Jun 30
EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042 Jun 26
Price target decreased by 11% to HK$8.03 Jun 26
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Jun 25 EC Healthcare, Annual General Meeting, Aug 23, 2023
EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023 Jun 20
Is There Now An Opportunity In EC Healthcare (HKG:2138)? Jun 15
EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023 Jun 13
Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital May 12
Is EC Healthcare (HKG:2138) Potentially Undervalued? Mar 08
EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends Feb 03
Price target increased to HK$9.33 Jan 10
Price target increased to HK$8.04 Jan 06
Upcoming dividend of HK$0.058 per share Dec 21
EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year Dec 20
Investor sentiment improved over the past week Dec 05
Consensus forecasts updated Dec 01
First half 2023 earnings released Nov 25
EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023 Nov 25
Price target decreased to HK$8.89 Nov 16
Less than half of directors are independent Nov 16 EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022 Nov 12
EC Healthcare to Report Q2, 2023 Results on Nov 24, 2022 Nov 09
Investor sentiment improved over the past week Nov 04
Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)? Oct 25
Price target decreased to HK$10.17 Oct 19
Investor sentiment deteriorated over the past week Oct 13
EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return Sep 20
Chairman & Co-CEO recently bought HK$587k worth of stock Sep 04
EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042 Sep 01
EC Healthcare Announces Executive Changes Sep 01
Upcoming dividend of HK$0.042 per share Aug 29
EC Healthcare Approves Final Dividend for the Year Ended 31 March 2022, Payable on 20 September 2022 Aug 24
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Jul 28
EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year Jul 28 EC Healthcare Proposes Final Dividend for the Year Ended 31 March 2022
EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042 Jul 14
EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042 Jun 26 EC Healthcare, Annual General Meeting, Aug 23, 2022
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Jun 24
EC Healthcare to Report Fiscal Year 2022 Final Results on Jun 23, 2022 Jun 09
When Should You Buy EC Healthcare (HKG:2138)? May 26
EC Healthcare (SEHK:2138) entered into agreement to acquire 75% stake in Mobile Medical International Holdings Limited from certain existing shareholders for HKD 41.25 million. May 24
Price target decreased to HK$14.00 Apr 27
Less than half of directors are independent Apr 27
EC Healthcare Provides Sales Guidance for the Year Ended 31 March, 2022 Apr 22
EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around Apr 18
EC Healthcare (SEHK:2138) completed the acquisition of Excellent Power Investments Limited from GenRx Holdings Limited. Apr 01
Investor sentiment deteriorated over the past week Mar 15
Chairman & Co-CEO recently bought HK$526k worth of stock Feb 25
Is It Too Late To Consider Buying EC Healthcare (HKG:2138)? Feb 24
EC Healthcare (SEHK:2138) entered into an agreement to acquire Excellent Power Investments Limited from GenRx Holdings Limited for HKD 68 million. Feb 17 주주 수익률 2138 HK Consumer Services HK 마켓 7D -2.9% -2.2% -0.5% 1Y -60.1% -18.7% 19.9%
전체 주주 수익률 보기
수익률 대 산업: 2138 지난 1년 동안 -18.7 %를 반환한 Hong Kong Consumer Services 업계보다 저조한 성과를 냈습니다.
수익률 대 시장: 2138 지난 1년 동안 19.9 %를 반환한 Hong Kong 시장보다 저조한 성과를 냈습니다.
가격 변동성 Is 2138's price volatile compared to industry and market? 2138 volatility 2138 Average Weekly Movement 16.5% Consumer Services Industry Average Movement 9.5% Market Average Movement 8.8% 10% most volatile stocks in HK Market 18.6% 10% least volatile stocks in HK Market 4.1%
안정적인 주가: 2138 의 주가는 지난 3개월 동안 변동성이 심했습니다.
시간에 따른 변동성: 2138 의 주간 변동성 ( 16% )은 지난 1년 동안 안정적이었지만 여전히 Hong Kong 의 75%보다 높습니다. 주식.
회사 소개 투자 지주 회사인 EC 헬스케어는 홍콩, 마카오, 중화인민공화국에서 의료 및 헬스케어 서비스를 제공하는 기업입니다. 이 회사는 의료, 에스테틱 의료, 미용 및 웰니스, 수의학 및 기타 부문을 통해 사업을 운영하고 있습니다. 또한 준의료, 미용 및 웰빙, 의료 영상, 의료 수술, 미용 의료, 미용 의료, 치과, 눈 및 모발 치료, 백신, 카이로프랙틱 서비스를 제공합니다.
자세히 보기 EC Healthcare 기본 사항 요약 EC Healthcare 의 수익과 매출은 시가총액과 어떻게 비교하나요? 2138 기본 통계 시가총액 HK$794.09m 수익(TTM ) -HK$11.50m 수익(TTM ) HK$4.15b
수익 및 수익 최신 수익 보고서의 주요 수익성 통계(TTM) 2138 손익 계산서(TTM ) 수익 HK$4.15b 수익 비용 HK$2.81b 총 이익 HK$1.34b 기타 비용 HK$1.36b 수익 -HK$11.50m
주당 순이익(EPS) -0.0097 총 마진 32.38% 순이익 마진 -0.28% 부채/자본 비율 35.0%
2138 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기 예정된 배당금을 받으려면 언제까지 2138 을 구매해야 하나요? EC Healthcare 배당 날짜 전 배당일 Dec 30 2024 배당금 지급일 Jan 24 2025 전 배당금까지의 일수 6 days 배당금 지급일까지의 일수 31 days
기업 분석 및 재무 데이터 현황 데이터 마지막 업데이트(UTC 시간) 기업 분석 2024/12/23 02:32 장 마감 주가 2024/12/23 00:00 수익 2024/09/30 연간 수익 2024/03/31
데이터 소스 기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.
패키지 데이터 기간 미국 소스 예시 * 회사 재무 10년 애널리스트 컨센서스 추정치 +3년 시장 가격 30년 소유권 10년 관리 10년 주요 개발 사항 10년
* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.
명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.
분석 모델 및 눈송이 이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.
Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.
산업 및 부문 메트릭 업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.
애널리스트 출처 EC Healthcare 10 애널리스트 중 1 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.
분석가 교육기관 Tingting Li BOCI Research Ltd. Zhuonan Xu China International Capital Corporation Limited null null China International Capital Corporation Limited
7 더 많은 분석가 보기 
